Melani de Silva
Adolescent Medicine · Richmond, VANPI 1891710265
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 137 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 16.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $848 and has fallen 75.7% since, to $206 in 2025.
Across 137 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tris Pharma Inc$419
- Corium, LLC$365
- Ironshore Pharmaceuticals Inc.$284
- Supernus Pharmaceuticals, Inc.$217
- Pfizer$198
- Neos Therapeutics, LP$198
- plus $842 from 15 others
What the payments were for
- Food & beverage$2,523100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tris Pharma Inc | 25 | $419 |
| Corium, LLC | 15 | $365 |
| Ironshore Pharmaceuticals Inc. | 14 | $284 |
| Supernus Pharmaceuticals, Inc. | 14 | $217 |
| Pfizer | 8 | $198 |
| Neos Therapeutics, LP | 19 | $198 |
| Merck | 8 | $124 |
| Novo Nordisk | 1 | $122 |
| Kaleo, Inc. | 7 | $112 |
| Collegium Pharmaceutical, Inc. | 5 | $88 |
| Alk-abello, Inc | 3 | $72 |
| Cranial Technologies, Inc | 4 | $61 |
| Sanofi Pasteur Inc. | 3 | $61 |
| Smith+Nephew | 1 | $42 |
| Adlon Therapeutics L.p. | 3 | $39 |
| Genentech USA, Inc. | 2 | $26 |
| Biogen | 1 | $24 |
| Verrica Pharmaceuticals Inc. | 1 | $21 |
| LNHC, Inc | 1 | $19 |
| Vertical Pharmaceuticals, LLC | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Dyanavel XR$246
- Quillichew ER$246
- Quillivant$246
- Ozempic$122
How this compares
$2,523 in reported general payments places this provider in the 80th percentile of 49 adolescent medicine providers in Virginia.
Other adolescent medicine in Richmond
- Peter HeymanRichmond$3K
- Charles TerryRichmond$2K
- Lora ChristianRichmond$2K
- Cheryl BelleRichmond$1K
- Jocelyn VergaraRichmond$1K
- Cristi WilsonRichmond$216
- Stephanie CreweRichmond$124
- George RoweRichmond$102
- Adam FalikRichmond$82
- An PhamRichmond$76
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.